A High-Throughput Assay Using Liquid Chromatography-Tandem Mass Spectrometry for Simultaneous In Vivo Phenotyping of 5 Major Cytochrome P450 Enzymes in Patients

被引:30
作者
Ghassabian, Sussan [1 ]
Chetty, Manoranjenni [1 ]
Tattam, Bruce N. [1 ]
Glen, John [2 ]
Rahme, Jeannie [2 ]
Stankovic, Zvijezdana [2 ]
Ramzan, Iqbal [1 ]
Murray, Michael [1 ]
McLachlan, Andrew J. [1 ,3 ]
机构
[1] Univ Sydney, Fac Pharm, Camperdown, NSW 2006, Australia
[2] Macquarie Hosp, N Ryde, NSW, Australia
[3] Concord Hosp, Ctr Educ & Res Ageing, Concord, NSW, Australia
基金
英国医学研究理事会;
关键词
phenotyping cocktail; cytochrome P450 activity; LC/MS/MS; mass spectrometry; XANTHINE-OXIDASE ACTIVITIES; DRUG-METABOLIZING-ENZYMES; COOPERSTOWN 5+1 COCKTAIL; N-ACETYLTRANSFERASE-2; MIDAZOLAM; PLASMA; ADULTS; CYP3A; PHARMACOKINETICS; CAFFEINE;
D O I
10.1097/FTD.0b013e318197e1bf
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The phenotyping cocktail is a practical approach for phenotyping of cytochrome P450 (CYP) enzymes in vivo. In this study, a liquid chromatography-tandem mass spectrometry method using a dual-extraction approach was developed and validated to quantity 5 selective substrates and their metabolites for the simultaneous phenotyping CYPs 1A2, 2C19, 2C9, 2D6, and 3A4 in patient blood samples. The assay was applied in a pilot study of I I patients with schizophrenia. Five blood samples were collected before and at 1, 2, 4, and 6 hours after administration of a phenotyping cock-tail consisting of 100 mg caffeine, 20 mg omeprazole, 25 mg losartan, 30 mg dextromethorphan, and 2 mg midazolam. The method successfully quantitated the CYP enzyme activities without serious side effects in patients. The ratios of metabolite to parent area under the concentration-time curve values were calculated over the 6-hour postdosage to reflect CYP2D6, CYP3A4, and CYP2C9 activities. The ratios of metabolite to parent plasma concentrations were calculated at 4-hour postdosage for CYP1A2 and at 4- or 6-hour postdose for CYP2C19, respectively The plasma concentration of midazolam at 4 hours was also estimated as another phenotyping index for CYP3A4 activity. The simultaneous assay of all these analytes in a single matrix (plasma) will increase the feasibility of CYP phenotyping in patients.
引用
收藏
页码:239 / 246
页数:8
相关论文
共 21 条
[1]   INTERACTION BETWEEN 2 PROBES USED FOR PHENOTYPING CYTOCHROMES P4501A2 (CAFFEINE) AND P4502E1 (CHLORZOXAZONE) IN HUMANS [J].
BERTHOU, F ;
GOASDUFF, T ;
LUCAS, D ;
DREANO, Y ;
LEBOT, MH ;
MENEZ, JF .
PHARMACOGENETICS, 1995, 5 (02) :72-79
[2]   Combined phenotypic assessment of cytochrome P450 1A2, 2C9, 2C19, 2D6, and 3A, N-acetyltransferase-2, and xanthine oxidase activities with the "Cooperstown 5+1 cocktail" [J].
Chainuvati, S ;
Nafziger, AN ;
Leeder, JS ;
Gaedigk, A ;
Kearns, GL ;
Sellers, E ;
Zhang, YH ;
Kashuba, ADM ;
Rowland, E ;
Bertino, JS .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 74 (05) :437-447
[3]   The Karolinska cocktail for phenotyping of five human cytochrome P450 enzymes [J].
Christensen, M ;
Andersson, K ;
Dalén, P ;
Mirghani, RA ;
Muirhead, GJ ;
Nordmark, A ;
Tybring, G ;
Wahlberg, A ;
Yasar, Ü ;
Bertilsson, L .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (06) :517-528
[4]   Appropriate phenotyping procedures for drug metabolizing enzymes and transporters in humans and their simultaneous use in the "cocktail" approach [J].
Fuhr, U. ;
Jetter, A. ;
Kirchheiner, J. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (02) :270-283
[5]   Evaluation of the drug interaction potential of aplaviroc, a novel human immunodeficiency virus entry inhibitor, using a modified Cooperstown 5+1 cocktail [J].
Johnson, BM ;
Song, IH ;
Adkison, KK ;
Borland, J ;
Fang, L ;
Lou, Y ;
Berrey, MM ;
Nafziger, AN ;
Piscitelli, SC ;
Bertino, JS .
JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (05) :577-587
[6]   Limited sampling strategy to predict AUC of the CYP3A phenotyping probe midazolam in adults: Application to various assay techniques [J].
Kim, JS ;
Nafziger, AN ;
Tsunoda, SM ;
Choo, EF ;
Streetman, DS ;
Kashuba, ADM ;
Kulawy, RW ;
Beck, DJ ;
Rocci, ML ;
Wilkinson, GR ;
Greenblatt, DJ ;
Bertino, JS .
JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (04) :376-382
[7]   Population pharmacokinetics of intravenous caffeine in neonates with apnea of prematurity [J].
Lee, TC ;
Charles, B ;
Steer, P ;
Flenady, V ;
Shearman, A .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 61 (06) :628-640
[8]   In-vivo phenotyping for CYP3A by a single-point determination of midazolam plasma concentration [J].
Lin, YS ;
Lockwood, GF ;
Graham, MA ;
Brian, WR ;
Loi, CM ;
Dobrinska, MR ;
Shen, DD ;
Watkins, PB ;
Wilkinson, GR ;
Kharasch, ED ;
Thummel, KE .
PHARMACOGENETICS, 2001, 11 (09) :781-791
[9]   Maribavir pharmacokinetics and the effects of multiple-dose maribavir on cytochrome P450 (CYP) 1A2, CYP2C9, CYP2C19, CYP 2D6, CYP 3A, N-acetyltransferase-2, and xanthine oxidase activities in healthy adults [J].
Ma, JD ;
Nafziger, AN ;
Villano, SA ;
Gaedigk, A ;
Bertino, JS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (04) :1130-1135
[10]   Clinical importance of the cytochromes P450 [J].
Nebert, DW ;
Russell, DW .
LANCET, 2002, 360 (9340) :1155-1162